Alzheimer’s disease and other forms of dementia are caused by abnormal protein buildups that damage and kill brain cells, but the triggers behind those buildups vary. Alzheimer’s accounts for the majority of dementia cases, while vascular problems, other misfolded proteins, and metabolic dysfunction each drive distinct types. Over 57 million people worldwide were living with dementia as of 2021, with nearly 10 million new cases each year.
Dementia is not a single disease. It’s an umbrella term for cognitive decline severe enough to interfere with daily life, and each type has its own biological story. Understanding what drives each one helps clarify why risk factors like genetics, sleep, blood pressure, and even air quality all play a role.
How Alzheimer’s Damages the Brain
Alzheimer’s disease involves two rogue proteins working in tandem. The first, amyloid-beta, is a fragment snipped from a larger protein on the surface of brain cells. Normally it gets cleared away. In Alzheimer’s, it clumps into sticky plaques that accumulate between neurons and disrupt their ability to communicate.
The second protein, tau, normally acts like a scaffolding inside neurons, stabilizing the tiny transport tubes (microtubules) that shuttle nutrients and signals along nerve fibers. In Alzheimer’s, tau becomes chemically altered in a way that causes it to detach from those tubes and tangle together. Without stable scaffolding, the internal structure of neurons collapses. Axons and dendrites break down, and the cells die.
Research suggests amyloid-beta acts first, triggering a cascade that leads to tau dysfunction. Amyloid buildup appears to initiate a feedback loop: more amyloid leads to more tau damage, which accelerates further amyloid accumulation. This vicious cycle can begin 15 to 20 years before a person notices any memory problems, which is why Alzheimer’s is so difficult to catch early.
Genetics and the APOE-e4 Gene
The single strongest genetic risk factor for common, late-onset Alzheimer’s is a variant of a gene called APOE. Everyone inherits two copies of APOE (one from each parent), and the gene comes in several versions. The e4 variant significantly raises risk: carrying one copy doubles or triples your chance of developing Alzheimer’s, and carrying two copies makes you 8 to 12 times more likely to develop it.
The APOE-e4 variant appears to interfere with how brain cells use insulin, which may eventually starve those cells of energy and lead to their death. This connection has led some researchers to informally call Alzheimer’s “Type 3 diabetes,” reflecting the idea that impaired insulin signaling in the brain is a core part of the disease. People with this metabolic dysfunction in the brain may face a risk 10 to 15 times higher than average.
Importantly, carrying APOE-e4 does not guarantee Alzheimer’s. Many people with the variant never develop the disease, and many people without it do. Rare, early-onset forms of Alzheimer’s (appearing before age 65) are linked to mutations in different genes that directly increase amyloid production, but these account for a small fraction of all cases.
Vascular Dementia: When Blood Flow Fails
Vascular dementia is the second most common type and results from conditions that interrupt blood flow and oxygen delivery to the brain. This includes strokes (both large and small), chronic damage to tiny blood vessels, bleeding from ruptured vessels, and sustained periods of reduced blood flow to the brain.
One hallmark of vascular dementia is damage to the brain’s “white matter,” the dense wiring that relays messages between different brain regions. When small blood vessels feeding that wiring become diseased, the connections degrade. On brain scans, this shows up as bright white patches. The cognitive decline that follows tends to be more stepwise than Alzheimer’s, often worsening suddenly after a vascular event rather than fading gradually.
The same conditions that raise heart attack and stroke risk also raise vascular dementia risk: high blood pressure, high cholesterol, diabetes, smoking, and obesity. This makes vascular dementia one of the most preventable forms, since many of its root causes respond to lifestyle changes and medical management.
Lewy Body Dementia
Lewy body dementia involves a different protein entirely: alpha-synuclein. This protein is found throughout the brain, and when it misfolds and clumps into deposits called Lewy bodies, it disrupts normal cell function. The same protein aggregation drives Parkinson’s disease, which is why the two conditions share so many features and sometimes overlap.
Early symptoms of Lewy body dementia look quite different from Alzheimer’s. Memory loss is less prominent at the start. Instead, the earliest signs tend to include vivid visual hallucinations, movement difficulties resembling Parkinson’s (stiffness, slow movement, tremor), disrupted REM sleep where people physically act out dreams, and problems with the autonomic nervous system like sudden blood pressure drops, dizziness, and falls. Many people with Lewy body dementia also develop Alzheimer’s-type plaques and tangles over time, complicating the picture.
Frontotemporal Dementia
Frontotemporal dementia (FTD) strikes the front and side regions of the brain, which control personality, behavior, and language. It tends to appear earlier than Alzheimer’s, often between ages 45 and 65, and its initial symptoms are behavioral rather than memory-related: personality shifts, loss of social awareness, impulsive decisions, or progressive difficulty finding words.
About half of people with FTD have abnormal tau protein in their brains, while the other half have accumulations of a different protein called TDP-43. A small percentage (roughly 5%) have buildup of a third protein called FUS. In familial cases passed through families, the most common genetic culprit is a mutation in a gene called C9ORF72, which is also the most common inherited cause of ALS (Lou Gehrig’s disease). Mutations in the tau gene itself or the progranulin gene can also drive familial FTD.
How Sleep Protects Against Protein Buildup
The brain has its own waste-clearance system, sometimes called the glymphatic system, that flushes out metabolic debris, including amyloid-beta. This system ramps up dramatically during sleep. During natural sleep, the spaces between brain cells expand by about 60%, allowing cerebrospinal fluid to flow more freely and wash away toxic proteins.
The deepest stage of sleep, known as slow-wave sleep, is when this cleaning process is most active. Research shows that even several nights of partial sleep deprivation don’t raise amyloid levels in cerebrospinal fluid as long as slow-wave sleep is preserved. In other words, it’s the quality of deep sleep that matters most, not just total hours. Interestingly, sleeping on your side appears to enhance this clearance system compared to sleeping on your back or stomach.
Chronic sleep disruption over years may allow amyloid and other waste products to accumulate faster than the brain can clear them, contributing to the long, silent buildup that precedes Alzheimer’s symptoms.
Air Pollution and Environmental Exposure
Fine particulate matter in air pollution (PM2.5, particles small enough to enter the bloodstream through the lungs) is an emerging risk factor for dementia. An NIH-funded study tracking more than 27,000 adults aged 50 and older over an average of about 10 years found that 15% developed dementia during follow-up, and higher PM2.5 exposure was consistently linked to greater risk.
Particulate matter from agriculture and wildfires showed the strongest specific associations with dementia risk. The researchers estimated that if the relationship is causal, as many as 188,000 cases of dementia per year in the U.S. could be attributable to PM2.5 exposure. The likely mechanism involves tiny particles crossing into the brain and triggering chronic inflammation, which accelerates the same protein-damage pathways already at work in Alzheimer’s and other dementias.
Risk Factors You Can Influence
No single cause explains most dementia cases. Late-onset Alzheimer’s in particular results from a pileup of genetic susceptibility, vascular health, metabolic function, sleep quality, and environmental exposures interacting over decades. But research consistently identifies several modifiable factors that meaningfully shift risk:
- Cardiovascular health: High blood pressure in midlife, untreated diabetes, obesity, and smoking all increase risk for both Alzheimer’s and vascular dementia. What protects your heart generally protects your brain.
- Physical activity: Regular exercise improves blood flow to the brain and may help clear amyloid more effectively.
- Sleep: Prioritizing consistent, deep sleep supports the brain’s waste-clearance system during the years when protein buildup is still reversible.
- Hearing loss: Untreated hearing loss in midlife is one of the largest modifiable risk factors for dementia, likely because reduced auditory input accelerates brain atrophy in regions involved in memory.
- Social and cognitive engagement: Sustained intellectual activity and strong social connections appear to build cognitive reserve, helping the brain compensate for early damage longer before symptoms appear.
The Lancet Commission on dementia prevention has estimated that up to 40% of dementia cases worldwide could theoretically be prevented or delayed by addressing modifiable risk factors. That figure won’t apply equally to everyone, especially those with strong genetic risk, but it underscores how much of dementia’s burden is shaped by factors that accumulate quietly across a lifetime rather than by any single event.